<DOC>
	<DOCNO>NCT00108797</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . This study compare effectiveness safety NovoSeven® FEIBA ( FEIBA VH ) haemophilia patient inhibitor treat joint bleeds .</brief_summary>
	<brief_title>Trial NovoSeven® Haemophilia - Joint Bleeds</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Diagnosis hemophilia A B inhibitor factor VIII IX , respectively</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>